Avanos Medical Inc. (AVNS) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Avanos Medical Inc.

NYSE: AVNS · Real-Time Price · USD
11.79
0.46 (4.06%)
At close: Oct 03, 2025, 3:59 PM
11.79
0.00%
After-hours: Oct 03, 2025, 05:30 PM EDT

Avanos Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
692.5M 689.2M 687.8M 681.5M 682.4M 680.1M 673.3M 681.6M 682.6M 684.1M 722.2M 734M 745.8M 761.3M 744.6M 736.2M 737.8M 715.1M
Cost of Revenue
318.4M 311.6M 305.2M 303.2M 301.5M 297M 293.6M 294M 290.3M 288M 310.9M 327.8M 347.8M 373.4M 370.8M 362.8M 356.7M 339M
Gross Profit
374.1M 377.6M 382.6M 378.3M 380.9M 383.1M 379.7M 387.6M 392.3M 396.1M 411.3M 406.2M 398M 387.9M 373.8M 373.4M 381.1M 376.1M
Operating Income
43.8M 52.6M 52.7M 62.4M 71.2M 66.9M 65M 60.2M 49.7M 49.7M 57.3M 59.1M 55.8M 59.2M 57.2M 74.1M 78.5M 80.5M
Interest Income
3.6M 6M 5.1M 5.3M 5.5M 3M 2.9M 2.6M 2M 1.7M 1.2M 500K 400K 200K 200K 300K 300K 500K
Pretax Income
-477.2M -395.1M -403.3M 26.1M 14M 2.7M -7.9M -2.5M 10.2M 22.9M 39.3M 49.3M 42.1M 26.3M 5.8M -65.9M -73M -70.7M
Net Income
-463.2M -384.6M -392.1M 15.7M 7.7M -62.2M -61.8M -55.4M -36M 44.6M 50.5M 43.6M -7.2M 18.2M 5.2M -52M 2.4M -38.5M
Selling & General & Admin
306.2M 300.4M 303.7M 288.6M 283.5M 289.5M 287.5M 299.8M 314M 317M 324.3M 317M 310.8M 296.9M 284.3M 265M 268.5M 261.8M
Research & Development
24.1M 24.6M 26.2M 27.3M 26.2M 26.7M 27.6M 28.3M 29.5M 30.7M 30.6M 30.7M 31.8M 31.8M 32.3M 34.3M 34.1M 33.8M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
330.3M 325M 329.9M 315.9M 309.7M 316.2M 314.7M 327.4M 342.6M 346.4M 354M 347.1M 342.2M 328.7M 316.6M 299.3M 302.6M 295.6M
Interest Expense
10.1M 11.2M 12.2M 12.7M 14.2M 14.6M 15M 14.7M 13M 12.2M 10M 7.7M 5.6M 3.8M 3.3M 5.3M 8.7M 12.1M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
648.7M 636.6M 635.1M 619.1M 611.2M 613.2M 608.3M 621.4M 632.9M 634.4M 664.9M 674.9M 690M 702.1M 687.4M 662.1M 659.3M 634.6M
Income Tax Expense
-15.9M -14.9M -17M 4.4M 7M 4.3M 2M 8.7M 1.6M 5.2M 8.4M 18.1M 57M 8.1M 600K -13.9M -75.4M -32.2M
Shares Outstanding (Basic)
46.1M 46.1M 46M 46M 45.9M 46.2M 46.2M 46.8M 46.8M 46.6M 46.5M 46.6M 47.2M 47.4M 48.2M 48.1M 48.1M 47.5M
Shares Outstanding (Diluted)
46.8M 46.8M 46M 46.6M 46.3M 46.2M 46.6M 46.8M 46.8M 46.6M 47M 47M 47.6M 47.8M 48.6M 48.1M 48.6M 48M
EPS (Basic)
-10.07 -8.37 -8.53 0.34 0.17 -1.33 -1.32 -1.19 -0.77 0.93 1.06 0.91 -0.16 0.39 0.11 -1.09 0.04 -0.81
EPS (Diluted)
-10.07 -8.37 -8.53 0.34 0.17 -1.33 -1.32 -1.19 -0.78 0.92 1.05 0.90 -0.16 0.38 0.10 -1.1 0.03 -0.81
EBITDA
-424.7M -340.2M -345.6M 84.7M 73.4M 61.5M 50.6M 55.6M 65.6M 77.3M 91.9M 97.7M 88M 69.8M 47.4M -21M -23.6M -16.6M
EBIT
-467.1M -383.9M -391.1M 38.8M 28.2M 17.3M 7.1M 12.2M 23.2M 35.1M 49.3M 57M 47.7M 30.1M 9.1M -60.6M -64.3M -58.6M
Depreciation & Amortization
42.4M 43.7M 45.5M 45.9M 45.2M 44.2M 43.5M 43.4M 42.4M 42.2M 42.6M 40.7M 40.3M 39.7M 38.3M 39.6M 40.7M 42M